PMID- 32489954
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20231103
IS  - 2319-9644 (Print)
IS  - 2279-042X (Electronic)
IS  - 2279-042X (Linking)
VI  - 9
IP  - 1
DP  - 2020 Jan-Mar
TI  - Pharmacist Interventions in Improving Clinical Outcomes in Patients with Type 2 
      Diabetes Mellitus Among the Underrepresented Population: A Collaborative 
      Ambulatory Care Pharmacy Practice (CAPP) Approach.
PG  - 3-9
LID - 10.4103/jrpp.JRPP_19_75 [doi]
AB  - OBJECTIVE: The objective of this study was to evaluate the impact of pharmacist's 
      interventions through a collaborative ambulatory care pharmacy practice (CAPP) 
      model in patients with type 2 diabetes mellitus (T2DM) among the underrepresented 
      population. METHODS: Eligible patients were 18 years and older with a diagnosis 
      of T2DM with or without comorbid cardiovascular disease risk factors. Patients 
      were enrolled through routine primary care provider referrals. During a 
      one-on-one, face-to-face scheduled clinic visit, the pharmacist provided a 
      comprehensive medication management by reviewing vital signs and laboratory 
      values, provided medication reconciliation and management, followed by medication 
      counseling through a CAPP approach in a primary care setting. The pharmacist 
      worked in close collaboration with the primary care provider to intervene on 
      medication therapy through recommendations to initiate, adjust, modify, or 
      discontinue drug therapy and order laboratory tests and drug concentration levels 
      as appropriate. Each visit was documented as a "PharmD Progress Note" in the 
      patient's electronic medical record. Follow-up visits were scheduled until 
      patients' targeted treatment goals were achieved. Primary and secondary outcome 
      data were collected and then analyzed. FINDINGS: A pharmacist saw 47 patients 
      over 12 months. Sixty-four percent of the participating patients were able to 
      achieve targeted treatment goals. A statistically significant decrease in the 
      mean change in hemoglobin A1c, diastolic blood pressure, fasting blood glucose, 
      and triglyceride levels was observed from the baseline which was -2.3%, -7.75 
      mmHg, -76.1 mg/dL, and -55.5 mg/dL, respectively. No significant changes in other 
      clinical outcomes were observed. CONCLUSION: The CAPP model demonstrated a 
      significant reduction in clinical endpoints in patients with T2DM among the 
      high-risk underrepresented population.
CI  - Copyright: (c) 2020 Journal of Research in Pharmacy Practice.
FAU - Chong, Mok Thoong
AU  - Chong MT
AD  - Department of Clinical and Administrative Sciences, American University of Health 
      Sciences, California, USA.
LA  - eng
PT  - Journal Article
DEP - 20200328
PL  - India
TA  - J Res Pharm Pract
JT  - Journal of research in pharmacy practice
JID - 101614023
PMC - PMC7235450
OTO - NOTNLM
OT  - Ambulatory care
OT  - clinical outcomes
OT  - collaborative ambulatory care pharmacy practice
OT  - diabetes mellitus
OT  - medication adherence
COIS- There are no conflicts of interest.
EDAT- 2020/06/04 06:00
MHDA- 2020/06/04 06:01
PMCR- 2020/03/28
CRDT- 2020/06/04 06:00
PHST- 2019/06/20 00:00 [received]
PHST- 2019/11/12 00:00 [accepted]
PHST- 2020/06/04 06:00 [entrez]
PHST- 2020/06/04 06:00 [pubmed]
PHST- 2020/06/04 06:01 [medline]
PHST- 2020/03/28 00:00 [pmc-release]
AID - JRPP-9-3 [pii]
AID - 10.4103/jrpp.JRPP_19_75 [doi]
PST - epublish
SO  - J Res Pharm Pract. 2020 Mar 28;9(1):3-9. doi: 10.4103/jrpp.JRPP_19_75. 
      eCollection 2020 Jan-Mar.